Home Cart Sign in  
Chemical Structure| 321661-62-5 Chemical Structure| 321661-62-5

Structure of Cytosporone B
CAS No.: 321661-62-5

Chemical Structure| 321661-62-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cytosporone B is a Nur77 agonist with EC50 of 0.278 nM. It inhibits cancer cell proliferation and tumor growth.

Synonyms: Csn-B; Dothiorelone G

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cytosporone B

CAS No. :321661-62-5
Formula : C18H26O5
M.W : 322.40
SMILES Code : O=C(OCC)CC1=CC(O)=CC(O)=C1C(CCCCCCC)=O
Synonyms :
Csn-B; Dothiorelone G
MDL No. :MFCD12912406
InChI Key :UVVWQQKSNZLUQA-UHFFFAOYSA-N
Pubchem ID :10687292

Safety of Cytosporone B

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
TE-1 cells 40 μM 48 hours Induced cell apoptosis, and IRF1 overexpression attenuated CsnB-induced apoptosis PMC11126585
PyMT primary tumor cells 10 μM 24 hours Inhibited fatty acid uptake and cell proliferation PMC7959534
5637 human urothelial cells 100 μM Post-invasion treatment after 30 min Assess post-invasion treatment efficacy; highest dose significantly reduced intracellular UPEC load PMC11436794
5637 human urothelial cells 1 μM, 10 μM, 100 μM 2, 4, 6 hours Evaluate CsnB's inhibitory effect on UPEC intracellular infection; results showed dose-dependent reduction in intracellular UPEC CFU PMC11436794
SK-N-BE(2)-C cells 25 μM and 100 μM 18 hours To evaluate the effect of Cytosporone B on Nurr1 transcription, results showed decreased activity at the highest concentrations PMC8006468
MCF-7 cells 10 μM 24 hours Inhibited fatty acid uptake and cell proliferation PMC7959534
PC12 cells 25 μM and 100 μM 18 hours To evaluate the effect of Cytosporone B on Nurr1 transcription, results showed decreased activity at the highest concentrations PMC8006468
HEK293T cells 25 μM and 100 μM 18 hours To evaluate the effect of Cytosporone B on Nurr1 transcription, results showed decreased activity at the highest concentrations PMC8006468
Kyse520 cells 20, 25, 30, 35, 40 μM 48 hours Inhibited ESCC cell proliferation, and IRF1 overexpression reversed the suppressive effects of CsnB PMC11126585
Human renal proximal tubular epithelial cells (HK-2 cells) 10 μg/ml 24 hours To investigate the effect of Csn-B on fibrotic protein expression in HK-2 cells, results showed that Csn-B significantly increased the expression of fibrotic proteins Fn and Col-I. PMC10169452

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice MMTV-PyMT mouse model Intravenous injection 10 mg/kg Inhibited breast cancer progression PMC7959534
Mice UPEC urinary tract infection model Intraperitoneal injection 5 mg/kg Started 1 day before infection and continued post-infection Evaluate CsnB's effect on UPEC bladder infection; significantly reduced IBC formation and bladder bacterial burden PMC11436794
Mice Cocaine self-administration model Intraperitoneal injection 10 mg/kg Single or repeated injections (twice daily for 4 days) Csn-B attenuated cocaine-induced behavioral responses by activating Nr4a1 and enhanced homeostatic gene transcription PMC6981219
Nude mice HCC xenograft model Tail vein injection 10 mg/kg Every three days for three weeks Csn-B suppresses HCC growth by stimulating WFDC21P expression PMC7067692
BALB/c nude mice TE-1 xenograft model Intraperitoneal injection 13 mg/kg Twice a week until the end of the experiment Inhibited ESCC tumor growth, and exogenous IRF1 expression significantly diminished the anticancer effect of CsnB PMC11126585
C57BL/6 mice Unilateral ureteral obstruction (UUO) model Oral gavage 50 mg/kg Once every other day starting 7 days before UUO surgery to 7 days after surgery To investigate the effect of Csn-B on UUO-induced renal interstitial fibrosis, results showed that Csn-B aggravated renal interstitial fibrosis, increased the expression of fibrotic proteins Fn and Col-I, and induced p38 MAPK phosphorylation. PMC10169452

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.10mL

0.62mL

0.31mL

15.51mL

3.10mL

1.55mL

31.02mL

6.20mL

3.10mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories